Search research articles
Contact Us
Filters
Showing results (91-100 of 120) with videos related to
Page
of 12
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 25, 2025
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations
Andrew McVea, Alexandra DiFilippo, Max McLachlan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 16, 2025
Genome-wide association analyses identify candidate loci for amyloid imaging and plasma biomarkers in adults with Down syndrome
M Muaaz Aslam, Lam-Ha T Dang, Ruyu Shi, et al.
Neurobiology of Aging
|
April 14, 2022
Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down's syndrome
Stephanie S G Brown, Elijah Mak, Isabel Clare, et al.
The Lancet. Neurology
|
June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study
Shorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
October 28, 2015
Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder
Benjamin L Handen, Michael G Aman, L Eugene Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 17, 2015
The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B
Patrick J Lao, Tobey J Betthauser, Ansel T Hillmer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 15, 2025
The Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS): A 10-year report
Benjamin L Handen, Mark Mapstone, Sigan Hartley, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 16, 2024
Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
Emily K Schworer, Benjamin L Handen, Melissa Petersen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
September 26, 2017
A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension
Benjamin L Handen, Evdokia Anagnostou, Michael G Aman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Jr-Jiun Liou, Tales Santini, Milos D Ikonomovic, et al.
Page
of 12
Search research articles
Search
Showing results (91-100 of 120) with videos related to
Sort By:
Page
of 12
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 25, 2025
PET-measured amyloid beta accumulates at an accelerated rate in Down syndrome compared to neurotypical populations
Andrew McVea, Alexandra DiFilippo, Max McLachlan, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
July 16, 2025
Genome-wide association analyses identify candidate loci for amyloid imaging and plasma biomarkers in adults with Down syndrome
M Muaaz Aslam, Lam-Ha T Dang, Ruyu Shi, et al.
Neurobiology of Aging
|
April 14, 2022
Support vector machine learning and diffusion-derived structural networks predict amyloid quantity and cognition in adults with Down's syndrome
Stephanie S G Brown, Elijah Mak, Isabel Clare, et al.
The Lancet. Neurology
|
June 20, 2025
Prediction of amyloid and tau brain deposition and cognitive decline in people with Down syndrome using plasma biomarkers: a longitudinal cohort study
Shorena Janelidze, Lyduine E Collij, Niklas Mattsson-Carlgren, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
October 28, 2015
Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder
Benjamin L Handen, Michael G Aman, L Eugene Arnold, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
June 17, 2015
The effects of normal aging on amyloid-β deposition in nondemented adults with Down syndrome as imaged by carbon 11-labeled Pittsburgh compound B
Patrick J Lao, Tobey J Betthauser, Ansel T Hillmer, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
May 15, 2025
The Alzheimer's Biomarker Consortium-Down Syndrome (ABC-DS): A 10-year report
Benjamin L Handen, Mark Mapstone, Sigan Hartley, et al.
Alzheimer'S & Dementia (Amsterdam, Netherlands)
|
April 16, 2024
Cognitive and functional performance and plasma biomarkers of early Alzheimer's disease in Down syndrome
Emily K Schworer, Benjamin L Handen, Melissa Petersen, et al.
Journal of the American Academy of Child and Adolescent Psychiatry
|
September 26, 2017
A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension
Benjamin L Handen, Evdokia Anagnostou, Michael G Aman, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
December 26, 2025
Biomarkers
Jr-Jiun Liou, Tales Santini, Milos D Ikonomovic, et al.
Page
of 12